[1]
|
Boetes, C., Barentsz, J.O., Mus, R.D., Van Der Sluis, R.F., van Erning, L.J., Hendriks, J.H., Holland, R. and Ruys, S.H. (1994) MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology, 193, 777-781.
|
[2]
|
Saslow, D., Boetes, C., Burke, W., et al. (2007) American cancer society guidelines for breast screening with MRI as an adjunct to mammography. A Cancer Journal for Clinicians, 57, 75-89.
|
[3]
|
Kuhl, C. (2007) The current status of breast MR imaging part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice1. Radiology, 244, 356-378. doi:10.1148/radiol.2442051620
|
[4]
|
Bartella, L., Morris, E.A., Dershaw, D.D., et al. (2006) Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: Preliminary study. Radiology, 239, 686- 692. doi:10.1148/radiol.2393051046
|
[5]
|
Cecil, K.M., Schnall, M.D., Siegelman, E.S., et al. (2001) The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Research and Treatment, 68, 45- 54. doi:10.1023/A:1017911211090
|
[6]
|
Katz-Brull, R., Lavin, P.T. and Lenkinski, R.E. (2002) Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. Journal of the National Cancer Institute, 94, 1197-1203.
doi:10.1093/jnci/94.16.1197
|
[7]
|
Sardanelli, F., Fausto, A. and Podo, F. (2008) MR spectroscopy of the breast. La radiologia Medica, 113, 56-64.
doi:10.1007/s11547-008-0228-y
|
[8]
|
Sardanelli, F., Fausto, A., Di Leo, G., et al. (2009) In vivo proton MR spectroscopy of the breast using the total cho-line peak integral as a marker of malignancy. American Journal of Roentgenology, 192, 1608-1617.
doi:10.2214/AJR.07.3521
|
[9]
|
Esteban, L.M., Sanz, G. and Borque, A. (2011) A step- by-step algorithm for combining diagnostic tests. Journal of Applied Statistics, 38, 899-911.
doi:10.1080/02664761003692373
|
[10]
|
Pepe, M.S. and Thompson, M.L. (2000) Combining diagnostic test results to increase accuracy. Biostatistics, 1, 123-140. doi:10.1093/biostatistics/1.2.123
|
[11]
|
Su, J.Q. and Liu, J.S. (1993) Linear combinations of multiple diagnostic markers. Journal of the American Statistical Association, 88, 1350-1355.
doi:10.1080/01621459.1993.10476417
|
[12]
|
Jacobs, M.A., Barker, P.B., Argani, P., et al. (2004) Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: A feasibility study. Journal of Magnetic Resonance Imaging, 21, 23-28.
doi:10.1002/jmri.20239
|
[13]
|
Dorrius, M.D., Pijnappel, R.M., van der Weide Jansen, M., et al. (2012) The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging. European radiology, 22, 915-922.
doi:10.1007/s00330-011-2322-0
|
[14]
|
Meisamy, S., Bolan, P.J., Baker, E.H., et al. (2005) Adding in vivo quantitative 1h MR spectroscopy to improve diagnostic accuracy of breast MR imaging: Preliminary results of observer performance study at 4.0 T. Radiology, 236, 465-475. doi:10.1148/radiol.2362040836
|
[15]
|
Lipnick, S., Liu, X., Sayre, J., et al. (2010) Combined DCE-MRI and single voxel 2D MRS for differentiation between benign and malignant breast lesions. NMR in Biomedicine, 23, 922-930. doi:10.1002/nbm.1511
|
[16]
|
Huang, W., Fisher, P.R., Dulaimy, K., et al. (2004) Detection of breast malignancy: Diagnostic MR protocol for improved specificity. Radiology, 232, 585-591.
doi:10.1148/radiol.2322030547
|
[17]
|
Bottomley, P.A. (1987) Spatial localization in NMR spectroscopy in vivo. Annals of the New York Academy of Sciences, 508, 333-348.
doi:10.1111/j.1749-6632.1987.tb32915.x
|
[18]
|
Ordidge, R.J., Bendall, M.R., Gordon, R.E., et al. (1985) Volume selection for in vivo biological spectroscopy. In: Govil, G., Khetrapal, C.L. and Saran, A., Eds., Magnetic Resonance in Biology and Medicine, McGraw-Hill, New Delhi, 387-397.
|
[19]
|
Kuhl, C.K., Mielcareck, P., Klaschik, S., et al. (1999) Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology, 211, 101-110.
|
[20]
|
Baik, H.M., Su, M.Y., Yu, H., et al. (2006) Quantification of choline-containing compounds in malignant breast tumors by 1 H MR spectroscopy using water as an internal reference at 1.5 T. Magnetic Resonance Materials in Physics, Biology and Medicine, 19, 96-104.
|
[21]
|
Jagannathan, N. (2009) Quantitative estimate of in-vivo metabolites in breast and prostate tissues by MR spectroscopy. Medical Physics, 36, 2768.
doi:10.1118/1.3182501
|
[22]
|
Vanhamme, L., Van Den Boogaart, A. and Van Huffel, S. (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. Journal of Magnetic Resonance, 129, 35-43.
doi:10.1006/jmre.1997.1244
|
[23]
|
Stefan, D., Di Cesare, F., Andrasescu, A., et al. (2009) Quantitation of magnetic resonance spectroscopy signals: The jMRUI software package. Measurement Science and Technology, 20, 104035.
doi:10.1088/0957-0233/20/10/104035
|
[24]
|
Begg, C.B. (2006) Advances in statistical methodology for diagnostic medicine in the 1980’s. Statistics in Medicine, 10, 1887-1895. doi:10.1002/sim.4780101205
|
[25]
|
Swets, J.A. and Pickett, R.M. (1982) Evaluation of diagnostic systems: Methods from signal detection theory. Academic Press, New York.
|
[26]
|
Bolan, P.J., Meisamy, S., Baker, E.H., et al. (2003) In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magnetic Resonance in Medicine, 50, 1134-1143. doi:10.1002/mrm.10654
|
[27]
|
Haddadin, I.S., McIntosh, A., Meisamy, S., et al. (2009) Metabolite quantification and high field MRS in breast cancer. NMR in Biomedicine, 22, 65-76.
doi:10.1002/nbm.1217
|
[28]
|
Bakken, I.J., Gribbestad, I.S., Singstad, T.E., et al. (2001) External standard method for the in vivo quantification of choline containing compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla. Magnetic Resonance in Medicine, 46, 189-192. doi:10.1002/mrm.1175
|
[29]
|
Baek, H.M., Chen, J.H., Yu, H.J., et al. (2008) Detection of choline signal in human breast lesions with chemical shift imaging. Journal of Magnetic Resonance Imaging, 27, 1114-1121. doi:10.1002/jmri.21309
|
[30]
|
Baik, H.M., Su, M.Y., Yu, H.J., et al. (2005) Proton chemical shift imaging for monitoring early treatment response of breast cancer to neoadjuvant chemotherapy. Proceedings of the 13th Annual ISMRM, 7-13 May 2005, Miami.
|
[31]
|
Do, R., Moy, L., Salibi, N., et al. (2006) Can MRS improve our ability to distinguish between benign and malignant lesions? Proceedings of the 14th Annual ISMRM, 6-12 May 2006, Seattle, Washington DC.
|
[32]
|
Jacobs, M.A., Barker, P.B., Bottomley, P.A., et al. (2004) Proton magnetic resonance spectroscopic imaging of human breast cancer: A preliminary study. Journal of Magnetic Resonance Imaging, 19, 68-75.
doi:10.1002/jmri.10427
|
[33]
|
Stanwell, P., Gluch, L., Clark, D., et al. (2005) Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1 H MRS at 1.5 T. European Radiology, 15, 1037-1043. doi:10.1007/s00330-004-2475-1
|
[34]
|
Huang, W., Tudorica, L.A., Li, X., et al. (2011) Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging. Radiology, 261, 394-403.
doi:10.1148/radiol.11102413
|